|
1
|
Kobiyama K and Ley K: Atherosclerosis.
Circ Res. 123:1118–1120. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Byrne RA, Rossello X, Coughlan JJ, Barbato
E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, et
al: 2023 ESC guidelines for the management of acute coronary
syndromes. Eur Heart J. 44:3720–3826. 2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Luca AC, David SG, David AG, Tarca V,
Paduret IA, Mindru DE, Rosu ST, Rosu EV, Adumitrachioaiei H, Bernic
J, et al: Atherosclerosis from newborn to Adult-epidemiology,
pathological aspects, and risk factors. Life (Basel).
13(2056)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bezsonov EE, Sobenin IA and Orekhov AN:
Immunopathology of atherosclerosis and related diseases: Focus on
molecular biology. Int J Mol Sci. 22(4080)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Xu Y, Zeng X and Tu WJ: Editorial:
Pathophysiology, treatment and rehabilitation of
atherosclerosis-related diseases in geriatric population. Front Med
(Lausanne). 11(1358769)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gasser TC, Ogden RW and Holzapfel GA:
Hyperelastic modelling of arterial layers with distributed collagen
fibre orientations. J R Soc Interface. 3:15–35. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Seidelmann SB, Lighthouse JK and Greif DM:
Development and pathologies of the arterial wall. Cell Mol Life
Sci. 71:1977–1999. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pyrpyris N, Dimitriadis K, Beneki E,
Iliakis P, Soulaidopoulos S, Tsioufis P, Adamopoulou E, Kasiakogias
A, Sakalidis A, Koutsopoulos G, et al: LOX-1 receptor: A diagnostic
tool and therapeutic target in atherogenesis. Curr Probl Cardiol.
49(102117)2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lubrano V, Ndreu R and Balzan S: Classes
of lipid mediators and their effects on vascular inflammation in
atherosclerosis. Int J Mol Sci. 24(1637)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ
and Han M: Inflammation and atherosclerosis: Signaling pathways and
therapeutic intervention. Signal Transduct Target Ther.
7(131)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zaman MJS: Prognosis of angina and
myocardial infarction in South Asian and White populations in the
United Kingdom: UCL (University College London), 2009.
|
|
12
|
Gunata M and Parlakpinar H: A review of
myocardial ischaemia/reperfusion injury: Pathophysiology,
experimental models, biomarkers, genetics and pharmacological
treatment. Cell Biochem Funct. 39:190–217. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cheng H, Zhong W, Wang L, Zhang Q, Ma X,
Wang Y, Wang S, He C, Wei Q and Fu C: Effects of shear stress on
vascular endothelial functions in atherosclerosis and potential
therapeutic approaches. Biomed Pharmacother.
158(114198)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang B, Tang X, Yao L, Wang Y, Chen Z, Li
M, Wu N, Wu D, Dai X, Jiang H and Ai D: Disruption of USP9X in
macrophages promotes foam cell formation and atherosclerosis. J
Clin Invest. 132(e154217)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang X, Shen Y, Shang M, Liu X and Munn
LL: Endothelial mechanobiology in atherosclerosis. Cardiovasc Res.
119:1656–1675. 2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Morrison AM, Sullivan AE and Aday AW:
Atherosclerotic disease: Pathogenesis and approaches to management.
Med Clin North Am. 107:793–805. 2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pi H, Wang G, Wang Y, Zhang M, He Q, Zheng
X, Yin K, Zhao G and Jiang T: Immunological perspectives on
atherosclerotic plaque formation and progression. Front Immunol.
15(1437821)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wu J, He S, Song Z, Chen S, Lin X, Sun H,
Zhou P, Peng Q, Du S, Zheng S and Liu X: Macrophage polarization
states in atherosclerosis. Front Immunol.
14(1185587)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li H, Cao Z, Wang L, Liu C, Lin H, Tang Y
and Yao P: Macrophage subsets and death are responsible for
atherosclerotic plaque formation. Front Immunol.
13(843712)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Libby P: Inflammation during the life
cycle of the atherosclerotic plaque. Cardiovasc Res. 117:2525–2536.
2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bentzon JF, Otsuka F, Virmani R and Falk
E: Mechanisms of plaque formation and rupture. Circ Res.
114:1852–1866. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Henein MY, Vancheri S, Longo G and
Vancheri F: The role of inflammation in cardiovascular disease. Int
J Mol Sci. 23(12906)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sijbesma JWA, van Waarde A, Kristensen S,
Kion I, Tietge UJF, Hillebrands JL, Bulthuis MLC, Buikema H,
Nakladal D, Westerterp M, et al: Characterization of a novel model
for atherosclerosis imaging: The apolipoprotein E-deficient rat.
EJNMMI Res. 13(106)2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
van der Vaart JI, van Eenige R, Rensen PCN
and Kooijman S: Atherosclerosis: An overview of mouse models and a
detailed methodology to quantify lesions in the aortic root. Vasc
Biol. 6(e230017)2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Benitez-Amaro A, Garcia E, La Chica Lhoëst
MT, Martínez A, Borràs C, Tondo M, Céspedes MV, Caruana P, Pepe A,
Bochicchio B, et al: Targeting LDL aggregation decreases
atherosclerotic lipid burden in a humanized mouse model of familial
hypercholesterolemia: Crucial role of ApoB100 conformational
stabilization. Atherosclerosis. 410(118630)2025.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Louloudis G, Ambrosini S, Paneni F, Camici
GG, Benke D and Klohs J: Adeno-associated Virus-mediated
Gain-of-Function mPCSK9 expression in the mouse induces
hypercholesterolemia, monocytosis, neutrophilia, and a
hypercoagulative state. Front Cardiovasc Med.
8(718741)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gargiulo S, Gramanzini M and Mancini M:
Molecular imaging of vulnerable atherosclerotic plaques in animal
models. Int J Mol Sci. 17(1511)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kumar V, Abbas AK, Aster JC and Deyrup AT:
Robbins & Kumar basic pathology, e-book: Robbins & Kumar
basic pathology, e-book: Elsevier Health Sciences, 2022.
|
|
29
|
Sawhney JPS and Madan K: Familial
hypercholesterolemia. Indian Heart J. 76 (Suppl 1):S108–S112.
2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wong ND, Budoff MJ, Ferdinand K, Graham
IM, Michos ED, Reddy T, Shapiro MD and Toth PP: Atherosclerotic
cardiovascular disease risk assessment: An American Society for
Preventive Cardiology clinical practice statement. Am J Prev
Cardiol. 10(100335)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Costopoulos C, Liew TV and Bennett M:
Ageing and atherosclerosis: Mechanisms and therapeutic options.
Biochem Pharmacol. 75:1251–1261. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yerly A, van der Vorst EPC, Baumgartner I,
Bernhard SM, Schindewolf M and Doring Y: Sex-specific and
hormone-related differences in vascular remodelling in
atherosclerosis. Eur J Clin Invest. 53(e13885)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kotsovilis S, Salagianni M, Varela A,
Davos CH, Galani IE and Andreakos E: Comprehensive analysis of
1-year-old female apolipoprotein E-deficient mice reveals advanced
atherosclerosis with vulnerable plaque characteristics. Int J Mol
Sci. 25(1355)2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Karr S: Epidemiology and management of
hyperlipidemia. Am J Manag Care. 23 (Suppl 9):S139–S148.
2017.PubMed/NCBI
|
|
35
|
Mach F, Baigent C, Catapano AL, Koskinas
KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V,
Ference BA, et al: 2019 ESC/EAS guidelines for the management of
dyslipidaemias: Lipid modification to reduce cardiovascular risk.
Eur Heart J. 41:111–188. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dutka M, Zimmer K, Ćwiertnia M, Ilczak T
and Bobiński R: The role of PCSK9 in heart failure and other
cardiovascular diseases-mechanisms of action beyond its effect on
LDL cholesterol. Heart Fail Rev. 29:917–937. 2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
McEvoy JW, McCarthy CP, Bruno RM, Brouwers
S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro
CJ, Gerdts E, et al: 2024 ESC guidelines for the management of
elevated blood pressure and hypertension. Eur Heart J.
45:3912–4018. 2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ishida M, Sakai C, Kobayashi Y and Ishida
T: Cigarette smoking and atherosclerotic cardiovascular disease. J
Atheroscler Thromb. 31:189–200. 2024.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Poznyak A, Grechko AV, Poggio P,
Myasoedova VA, Alfieri V and Orekhov AN: The diabetes
Mellitus-atherosclerosis connection: The role of lipid and glucose
metabolism and chronic inflammation. Int J Mol Sci.
21(1835)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Attiq A, Afzal S, Ahmad W and Kandeel M:
Hegemony of inflammation in atherosclerosis and coronary artery
disease. Eur J Pharmacol. 966(176338)2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zuchi C, Tritto I, Carluccio E, Mattei C,
Cattadori G and Ambrosio G: Role of endothelial dysfunction in
heart failure. Heart Fail Rev. 25:21–30. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Grinan R, Escola-Gil JC, Julve J, Benitez
S and Rotllan N: Epigenetic regulation by microRNAs in
Hyperhomocysteinemia-accelerated atherosclerosis. Int J Mol Sci.
23(12452)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fahed G, Aoun L, Bou Zerdan M, Allam S,
Bou Zerdan M, Bouferraa Y and Assi HI: Metabolic syndrome: Updates
on pathophysiology and management in 2021. Int J Mol Sci.
23(786)2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bjorkegren JLM and Lusis AJ:
Atherosclerosis: Recent developments. Cell. 185:1630–1645.
2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Asada S and Kitamura T: Clonal
hematopoiesis and associated diseases: A review of recent findings.
Cancer Sci. 112:3962–3971. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Mach F, Baigent C, Catapano AL, Koskinas
KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V,
Ference BA, et al: 2019 ESC/EAS guidelines for the management of
dyslipidaemias: Lipid modification to reduce cardiovascular risk:
The Task Force for the management of dyslipidaemias of the European
Society of Cardiology (ESC) and European Atherosclerosis Society
(EAS). Eur Heart J. 41:111–188. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Masson W, Barbagelata L, Lavalle-Cobo A,
Corral P and Nogueira JP: Lipoprotein(a) and heart failure: A
systematic review. Heart Fail Rev. 28:1307–1314. 2023.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hou CY, Chen YW, Hazeena SH, Tain YL,
Hsieh CW, Chen DQ, Liu RY and Shih MK: Cardiovascular risk of
dietary trimethylamine oxide precursors and the therapeutic
potential of resveratrol and its derivatives. FEBS Open Bio.
14:358–379. 2024.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Loscalzo J, Fauci A, Kasper D, Hauser S,
Longo D and Jameson JL: Harrison's Principles of Internal Medicine,
21e. New York, NY, McGraw-Hill Education, 2022.
|
|
50
|
Gornik HL, Aronow HD, Goodney PP, Arya S,
Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK,
et al: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS
guideline for the management of lower extremity peripheral artery
disease: A report of the American College of Cardiology/American
Heart association joint committee on clinical practice guidelines.
Circulation. 149:e1313–e1410. 2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Mazzolai L, Teixido-Tura G, Lanzi S, Boc
V, Bossone E, Brodmann M, Bura-Riviere A, De Backer J, Deglise S,
Della Corte A, et al: 2024 ESC guidelines for the management of
peripheral arterial and aortic diseases. Eur Heart J. 45:3538–3700.
2024.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Malakar AK, Choudhury D, Halder B, Paul P,
Uddin A and Chakraborty S: A review on coronary artery disease, its
risk factors, and therapeutics. J Cell Physiol. 234:16812–16823.
2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhao Y, Zhang X, Chen X and Wei Y:
Neuronal injuries in cerebral infarction and ischemic stroke: From
mechanisms to treatment (review). Int J Mol Med.
49(15)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Katan M and Luft A: Global burden of
stroke. Semin Neurol. 38:208–211. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Packard C, Chapman MJ, Sibartie M, Laufs U
and Masana L: . Intensive low-density lipoprotein cholesterol
lowering in cardiovascular disease prevention: Opportunities and
challenges. Heart. 107:1369–1375. 2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Patrono C, Morais J, Baigent C, Collet JP,
Fitzgerald D, Halvorsen S, Rocca B, Siegbahn A, Storey RF and
Vilahur G: Antiplatelet agents for the treatment and prevention of
coronary atherothrombosis. J Am Coll Cardiol. 70:1760–1776.
2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Simon F, Larena-Avellaneda A and Wipper S:
Experimental atherosclerosis research on large and small animal
models in vascular surgery. J Vasc Res. 59:221–228. 2022.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Poledne R and Jurcikova-Novotna L:
Experimental models of hyperlipoproteinemia and atherosclerosis.
Physiol Res. 66 (Suppl 1):S69–S75. 2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhang Y, Fatima M, Hou S, Bai L, Zhao S
and Liu E: Research methods for animal models of atherosclerosis
(review) Mol Med. Rep. 24(871)2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Kamato D, Ilyas I, Xu S and Little PJ:
Non-mouse models of atherosclerosis: Approaches to exploring the
translational potential of new therapies. Int J Mol Sci.
23(12964)2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Golforoush P, Yellon DM and Davidson SM:
Mouse models of atherosclerosis and their suitability for the study
of myocardial infarction. Basic Res Cardiol. 115(73)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ignatowski A: Wirkung de tierischen
Nahrung auf den Kaninchenorganismus. Ber Milit Med Akad. 16:154–76.
1908.
|
|
63
|
Jawien J, Nastalek P and Korbut R: Mouse
models of experimental atherosclerosis. J Physiol Pharmacol.
55:503–517. 2004.PubMed/NCBI
|
|
64
|
Hill MF and Bordoni B: Hyperlipidemia:
StatPearls, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559182/.
|
|
65
|
Cunha LF, Ongaratto MA, Endres M and
Barschak AG: Modelling hypercholesterolaemia in rats using high
cholesterol diet. Int J Exp Pathol. 102:74–79. 2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Imaizumi K: Diet and atherosclerosis in
apolipoprotein E-deficient mice. Biosci Biotechnol Biochem.
75:1023–1035. 2011.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Fang L, Liu C and Miller YI: Zebrafish
models of dyslipidemia: Relevance to atherosclerosis and
angiogenesis. Transl Res. 163:99–108. 2014.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Gunata M and Parlakpinar H: Experimental
heart failure models in small animals. Heart Fail Rev. 28:533–554.
2023.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Fan J, Chen Y, Yan H, Niimi M, Wang Y and
Liang J: Principles and applications of rabbit models for
atherosclerosis research. J Atheroscler Thromb. 25:213–220.
2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Andreadou I, Schulz R, Badimon L, Adameova
A, Kleinbongard P, Lecour S, Nikolaou PE, Falcao-Pires I, Vilahur
G, Woudberg N, et al: Hyperlipidaemia and cardioprotection: Animal
models for translational studies. Br J Pharmacol. 177:5287–5311.
2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Cannizzo B, Lujan A, Estrella N, Lembo C,
Cruzado M and Castro C: Insulin resistance promotes early
atherosclerosis via increased proinflammatory proteins and
oxidative stress in fructose-fed ApoE-KO mice. Exp Diabetes Res.
2012(941304)2012.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Handayani D, Febrianingsih E, Desi
Kurniawati A, Kusumastuty I, Nurmalitasari S, Widyanto RM,
Oktaviani DN, Maghfirotun Innayah A and Sulistyowati E:
High-fructose diet initially promotes increased aortic wall
thickness, liver steatosis, and cardiac histopathology
deterioration, but does not increase body fat index. J Public
Health Res. 10(2181)2021.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Álvarez-Valadez MDR, Rodríguez-Hernández
A, Andrade-Urzúa F, Limón-Miranda S, Ceballos-Gutiérrez A,
Velasco-Gutiérrez JA, Gamboa-Domínguez A, Virgen-Ortiz A and
Sánchez-Pastor E: Novel murine model of atherosclerosis progression
induced by a modified paigen diet. Biomedicines.
13(2736)2025.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Sohn EJ, Kang DG, Choi DH, Lee AS, Mun YJ,
Woo WH, Kim JS and Lee HS: Effect of methanol extract of Sorbus
cortex in a rat model of L-NAME-induced atherosclerosis. Biol Pharm
Bull. 28:1239–1243. 2005.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Yu L, Gao R, Song X, Li X and Zhu J:
Cardio-protective and Anti-atherosclerosis Effect of Crocetin on
Vitamin D3 and HFD-induced Atherosclerosis in Rats. J Oleo Sci.
70:1447–1459. 2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Ding L, Chang M, Guo Y, Zhang L, Xue C,
Yanagita T, Zhang T and Wang Y: Trimethylamine-N-oxide
(TMAO)-induced atherosclerosis is associated with bile acid
metabolism. Lipids Health Dis. 17(286)2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Qin W, Zhang L, Li Z, Xiao D, Zhang Y,
Zhang H, Mokembo JN, Monayo SM, Jha NK, Kopylov P, et al:
Endothelial to mesenchymal transition contributes to
nicotine-induced atherosclerosis. Theranostics. 10:5276–5289.
2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Ye J, Li L, Wang M, Ma Q, Tian Y, Zhang Q,
Liu J, Li B, Zhang B, Liu H, et al: Diabetes mellitus promotes the
development of atherosclerosis: The role of NLRP3. Front Immunol.
13(900254)2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ
Jr, Chow WS, Stern D and Schmidt AM: Suppression of accelerated
diabetic atherosclerosis by the soluble receptor for advanced
glycation endproducts. Nat Med. 4:1025–1031. 1998.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Choi JSY, de Haan JB and Sharma A: Animal
models of diabetes-associated vascular diseases: An update on
available models and experimental analysis. Br J Pharmacol.
179:748–769. 2022.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Furman BL: Streptozotocin-Induced diabetic
models in mice and rats. Curr Protoc. 1(e78)2021.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Johansson F, Kramer F, Barnhart S, Kanter
JE, Vaisar T, Merrill RD, Geng L, Oka K, Chan L, Chait A, et al:
Type 1 diabetes promotes disruption of advanced atherosclerotic
lesions in LDL receptor-deficient mice. Proc Natl Acad Sci USA.
105:2082–2087. 2008.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Sanada J, Kimura T, Shimoda M, Iwamoto Y,
Iwamoto H, Dan K, Fushimi Y, Katakura Y, Nogami Y, Shirakiya Y, et
al: Protective effects of imeglimin on the development of
atherosclerosis in ApoE KO mice treated with STZ. Cardiovasc
Diabetol. 23(105)2024.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Wendt T, Harja E, Bucciarelli L, Qu W, Lu
Y, Rong LL, Jenkins DG, Stein G, Schmidt AM and Yan SF: RAGE
modulates vascular inflammation and atherosclerosis in a murine
model of type 2 diabetes. Atherosclerosis. 185:70–77.
2006.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Wu KK, Wu TJ, Chin J, Mitnaul LJ,
Hernandez M, Cai TQ, Ren N, Waters MG, Wright SD and Cheng K:
Increased hypercholesterolemia and atherosclerosis in mice lacking
both ApoE and leptin receptor. Atherosclerosis. 181:251–259.
2005.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Lantos I, Endresz V, Virok DP, Szabo A, Lu
X, Mosolygo T and Burian K: Chlamydia pneumoniae infection
exacerbates atherosclerosis in ApoB100only/LDLR(-/-) mouse strain.
Biomed Res Int. 2018(8325915)2018.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Du Y, Zhang G and Liu Z: Human
cytomegalovirus infection and coronary heart disease: A systematic
review. Virol J. 15(31)2018.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Volobueva AS, Orekhov AN and Deykin AV: An
update on the tools for creating transgenic animal models of human
diseases-focus on atherosclerosis. Braz J Med Biol Res.
52(e8108)2019.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Piedrahita JA, Zhang SH, Hagaman JR,
Oliver PM and Maeda N: Generation of mice carrying a mutant
apolipoprotein E gene inactivated by gene targeting in embryonic
stem cells. Proc Natl Acad Sci USA. 89:4471–4475. 1992.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Paniagua-Sancho M, Casanova AG,
Rodríguez-Estévez L, Cruz-González I, López-Hernández FJ and
Martínez-Salgado C: Pathophysiological characterization of the
ApoE-/-;db/db mouse: A model of diabetes and atherosclerosis.
Methods. 234:223–232. 2025.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Lu R, Yuan T, Wang Y, Zhang T, Yuan Y, Wu
D, Zhou M, He Z, Lu Y, Chen Y, et al: Spontaneous severe
hypercholesterolemia and atherosclerosis lesions in rabbits with
deficiency of Low-density lipoprotein receptor (LDLR) on exon 7.
EBioMedicine. 36:29–38. 2018.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Emini Veseli B, Perrotta P, De Meyer GRA,
Roth L, Van der Donckt C, Martinet W and De Meyer GRY: Animal
models of atherosclerosis. Eur J Pharmacol. 816:3–13.
2017.PubMed/NCBI View Article : Google Scholar
|
|
93
|
van Dijk KW, van Vlijmen BJ, de Winther
MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM and
Hofker MH: Hyperlipidemia of ApoE2 (Arg(158)-Cys) and ApoE3-Leiden
transgenic mice is modulated predominantly by LDL receptor
expression. Arterioscler Thromb Vasc Biol. 19:2945–2951.
1999.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Oppi S, Luscher TF and Stein S: Mouse
models for atherosclerosis Research-Which is my line? Front
Cardiovasc Med. 6(46)2019.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Roth L, Rombouts M, Schrijvers DM, Emini
Veseli B, Martinet W and De Meyer GRY: Acetylsalicylic acid reduces
passive aortic wall stiffness and cardiovascular remodelling in a
mouse model of advanced atherosclerosis. Int J Mol Sci.
23(404)2021.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Kounatidis D, Vallianou NG, Poulaki A,
Evangelopoulos A, Panagopoulos F, Stratigou T, Geladari E,
Karampela I and Dalamaga M: ApoB100 and Atherosclerosis: What's New
in the 21st Century? Metabolites. 14(123)2024.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Peng X: Transgenic rabbit models for
studying human cardiovascular diseases. Comp Med. 62:472–479.
2012.PubMed/NCBI
|
|
98
|
Veniant MM, Withycombe S and Young SG:
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-)
and Lldr(-/-) mice. Arterioscler Thromb Vasc Biol. 21:1567–1570.
2001.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Rosales C, Gillard BK, Xu B, Gotto AM Jr
and Pownall HJ: Revisiting reverse cholesterol transport in the
context of High-density lipoprotein free cholesterol
bioavailability. Methodist Debakey Cardiovasc J. 15:47–54.
2019.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Starsichova A: SR-B1-/-ApoE-R61h/h Mice
mimic human coronary heart disease. Cardiovasc Drugs Ther.
38:1123–1137. 2024.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Su S, Chen Z, Ke Q, Kocher O, Krieger M
and Kang PM: Nanoparticle-directed antioxidant therapy can
ameliorate disease progression in a novel, Diet-inducible model of
coronary artery disease. Arterioscler Thromb Vasc Biol.
44:2476–2488. 2024.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Bjorklund MM, Hollensen AK, Hagensen MK,
Dagnaes-Hansen F, Christoffersen C, Mikkelsen JG and Bentzon JF:
Induction of atherosclerosis in mice and hamsters without germline
genetic engineering. Circ Res. 114:1684–1689. 2014.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Jennings DL, Sultan L, Mingov J, Choe J,
Latif F, Restaino S, Clerkin K, Habal MV, Colombo PC, Yuzefpulskaya
M, et al: PCSK9 inhibitors safely and effectively lower LDL after
heart transplantation: A systematic review and meta-analysis. Heart
Fail Rev. 28:149–156. 2023.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Roche-Molina M, Sanz-Rosa D, Cruz FM,
Garcia-Prieto J, Lopez S, Abia R, Muriana FJ, Fuster V, Ibanez B
and Bernal JA: Induction of sustained hypercholesterolemia by
single adeno-associated virus-mediated gene transfer of mutant
hPCSK9. Arterioscler Thromb Vasc Biol. 35:50–59. 2015.PubMed/NCBI View Article : Google Scholar
|
|
105
|
de Mol J, Smit V, Kleijn M, van Santbrink
PJ, Bot I and Foks AC: Immunosenescence accelerates atherosclerosis
development in AAV-PCSK9 mouse model. Geroscience. 47:6549–6563.
2025.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Lawn RM, Wade DP, Hammer RE, Chiesa G,
Verstuyft JG and Rubin EM: Atherogenesis in transgenic mice
expressing human apolipoprotein(a). Nature. 360:670–672.
1992.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Ishibashi S: Lipoprotein(a) and
atherosclerosis. Arterioscler Thromb Vasc Biol. 21:1–2.
2001.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Kitajima S, Jin Y, Koike T, Yu Y, Liu E,
Shiomi M, Marcovina SM, Morimoto M, Watanabe T and Fan J: Lp(a)
enhances coronary atherosclerosis in transgenic Watanabe heritable
hyperlipidemic rabbits. Atherosclerosis. 193:269–276.
2007.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Chen T, Sun M, Wang JQ, Cui JJ, Liu ZH and
Yu B: A novel swine model for evaluation of dyslipidemia and
atherosclerosis induced by human CETP overexpression. Lipids Health
Dis. 16(169)2017.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Karackattu SL, Trigatti B and Krieger M:
Hepatic lipase deficiency delays atherosclerosis, myocardial
infarction, and cardiac dysfunction and extends lifespan in
SR-BI/apolipoprotein E double knockout mice. Arterioscler Thromb
Vasc Biol. 26:548–554. 2006.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Zhu L, Lu HS and Daugherty A: Is IDOL an
ideal target for treating atherosclerosis? Arterioscler Thromb Vasc
Biol. 45:672–674. 2025.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Shiomi M: The history of the WHHL rabbit,
an animal model of familial hypercholesterolemia (II)-Contribution
to the development and validation of the therapeutics for
hypercholesterolemia and atherosclerosis. J Atheroscler Thromb.
27:119–131. 2020.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Moghadasian MH, Frohlich JJ and McManus
BM: Advances in experimental dyslipidemia and atherosclerosis. Lab
Invest. 81:1173–1183. 2001.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Abd Rahim IN, Mohd Kasim NA, Omar E, Abd
Muid S and Nawawi H: Evaluation on the effectiveness of high
cholesterol diet feeding in inducing early and established
atherosclerotic lesions in new zealand white rabbits. Front Biosci
(Landmark Ed). 28(70)2023.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Giles DA, Ramkhelawon B, Donelan EM,
Stankiewicz TE, Hutchison SB, Mukherjee R, Cappelletti M, Karns R,
Karp CL, Moore KJ, et al: Modulation of ambient temperature
promotes inflammation and initiates atherosclerosis in wild type
C57BL/6 mice. Mol Metab. 5:1121–1130. 2016.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Ebert MLA, Schmidt VF, Öcal O, von Thaden
A, Dietrich O, Popper B, Elges S, Seidensticker M, Ricke J, Kimm
MA, et al: A minimally invasive animal model of atherosclerosis and
neointimal hyperplasia for translational research. Eur Radiol Exp.
9(14)2025.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Mitić T, Georgescu A, Alexandru-Moise N,
Davies MJ, Vindis C, Novella S, Gerdts E, Kararigas G, Wettinger
SB, Formosa MM, et al: Current status and challenges of multi-omics
research using animal models of atherosclerosis. J Mol Cell Cardiol
Plus. 13(100476)2025.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Kennedy AJ, Ellacott KL, King VL and Hasty
AH: Mouse models of the metabolic syndrome. Dis Model Mech.
3:156–166. 2010.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Amuzie C, Swart JR, Rogers CS, Vihtelic T,
Denham S and Mais DE: A Translational model for Diet-related
atherosclerosis: Effect of statins on hypercholesterolemia and
atherosclerosis in a minipig. Toxicol Pathol. 44:442–449.
2016.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Vedder VL, Aherrahrou Z and Erdmann J:
Dare to compare. Development of atherosclerotic lesions in human,
mouse, and Zebrafish. Front Cardiovasc Med. 7(109)2020.PubMed/NCBI View Article : Google Scholar
|
